These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35739041)

  • 1. Benefits and Harms of Deprescribing Antihyperglycemics for Adults With Type 2 Diabetes: A Systematic Review.
    Deng Z; Thompson W; Korenvain C; Lega IC; Farrell B; Lochnan H; McCarthy LM
    Can J Diabetes; 2022 Jul; 46(5):473-479. PubMed ID: 35739041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review.
    Black CD; Thompson W; Welch V; McCarthy L; Rojas-Fernandez C; Lochnan H; Shamji S; Upshur R; Farrell B
    Diabetes Ther; 2017 Feb; 8(1):23-31. PubMed ID: 27981503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial.
    Andriessen C; Blom MT; van Hoek BACE; de Boer AW; Denig P; de Wit GA; Swart K; de Rooij-Peek A; van Marum RJ; Hugtenburg JG; Slottje P; van Raalte D; van Bloemendaal L; Herings R; Nijpels G; Vos RC; Elders PJM
    Trials; 2024 Jul; 25(1):505. PubMed ID: 39049109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and Enablers for Deprescribing Glucose-Lowering Treatment in Older Adults: A Systematic Review.
    Mellot M; Jawal L; Morel T; Fournier JP; Tubach F; Cadwallader JS; Christiaens A; Zerah L
    J Am Med Dir Assoc; 2024 Mar; 25(3):439-447.e18. PubMed ID: 38237904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review.
    Oktora MP; Kerr KP; Hak E; Denig P
    Diabet Med; 2021 Feb; 38(2):e14408. PubMed ID: 32969063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline.
    Farrell B; Black C; Thompson W; McCarthy L; Rojas-Fernandez C; Lochnan H; Shamji S; Upshur R; Bouchard M; Welch V
    Can Fam Physician; 2017 Nov; 63(11):832-843. PubMed ID: 29138153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in deprescribing implementation trials and compliance with expert recommendations: a systematic review.
    Nizet P; Evin A; Brociero E; Vigneau CV; Huon JF
    BMC Geriatr; 2023 Jul; 23(1):428. PubMed ID: 37438697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis.
    Shrestha S; Poudel A; Cardona M; Steadman KJ; Nissen LM
    Ther Adv Drug Saf; 2021; 12():20420986211052343. PubMed ID: 34707802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes Towards Deprescribing Among Older Adults with Limited Life Expectancy and Their Relatives: A Systematic Review.
    Burghle A; Lundby C; Ryg J; Søndergaard J; Pottegård A; Nielsen D; Graabæk T
    Drugs Aging; 2020 Jul; 37(7):503-520. PubMed ID: 32537682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Deprescribing Improve Quality of Life? A Systematic Review of the Literature.
    Pruskowski JA; Springer S; Thorpe CT; Klein-Fedyshin M; Handler SM
    Drugs Aging; 2019 Dec; 36(12):1097-1110. PubMed ID: 31598908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprescribing in Older Adults With Cancer and Limited Life Expectancy: An Integrative Review.
    Brokaar EJ; van den Bos F; Visser LE; Portielje JEA
    Am J Hosp Palliat Care; 2022 Jan; 39(1):86-100. PubMed ID: 33739162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials.
    Crisafulli S; Luxi N; Coppini R; Capuano A; Scavone C; Zinzi A; Vecchi S; Onder G; Sultana J; Trifirò G
    BMC Fam Pract; 2021 Oct; 22(1):208. PubMed ID: 34666689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprescription in elderly patients with type 2 diabetes mellitus.
    Silverii GA; Caldini E; Dicembrini I; Pieri M; Monami M; Mannucci E
    Diabetes Res Clin Pract; 2020 Dec; 170():108498. PubMed ID: 33068664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing interventions in older adults: An overview of systematic reviews.
    Chua S; Todd A; Reeve E; Smith SM; Fox J; Elsisi Z; Hughes S; Husband A; Langford A; Merriman N; Harris JR; Devine B; Gray SL;
    PLoS One; 2024; 19(6):e0305215. PubMed ID: 38885276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.
    Thillainadesan J; Gnjidic D; Green S; Hilmer SN
    Drugs Aging; 2018 Apr; 35(4):303-319. PubMed ID: 29541966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.
    Thompson AM; Linnebur SA; Vande Griend JP; Saseen JJ
    Consult Pharm; 2014 Feb; 29(2):110-23. PubMed ID: 24513421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing in cardiometabolic conditions in older patients: a systematic review.
    Hickman E; Seawoodharry M; Gillies C; Khunti K; Seidu S
    Geroscience; 2023 Dec; 45(6):3491-3512. PubMed ID: 37402905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tools for deprescribing in severe dementia: A scoping review.
    Wang C; Roberts E; Smith G; Carland JE; Cordato NJ
    Int J Geriatr Psychiatry; 2023 Jul; 38(7):e5959. PubMed ID: 37395164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.